New Key Statistics Module, Z-Score and F-Score
NAS:FHTX Key Ratios
| Market Cap $ M | 234.65 |
| Enterprise Value $ M | 83.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 7.21 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 33.00 |
| EPS (TTM) $ | -2.20 |
| Beneish M-Score | -1.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -8.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.81 |
| EV-to-EBITDA | -0.84 |
| PEG | -- |
| Shares Outstanding M | 42.59 |
| Net Margin (%) | -274.23 |
| Operating Margin % | -303.23 |
| Pre-tax Margin (%) | -263.42 |
| Quick Ratio | 4.06 |
| Current Ratio | 4.06 |
| ROA % (ttm) | -29.66 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -117.80 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.58 |
FHTX Number of Guru Trades
FHTX Volume of Guru Trades
Gurus Latest Trades with NAS:FHTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FHTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Foghorn Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FHTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers